Hypoglycaemia as predictor of cardiovascular accidents

封面

如何引用文章

全文:

详细

Diabetes mellitus type 2 is not only a chronic disease, but also refers to a group of constantly progressing pathologies. Regardless of the level of development of medicine and used therapeutic approaches, mortality from cardio-vascular complications of diabetes exceeds the figures of the General population. According to the results of Veterans Affairs Diabetes Trial it was revealed that severe hypoglycemia are predictors for the development of myocardial infarction and acute disturbance of cerebral blood circulation. Pledge of successful treatment of patients with type 2 diabetes is the adequate choice of target values of glycemia and maintaining it by means of a combination of curative (observance of dietary recommendations, reception of hypoglycemic drugs, etc.) and not drug-induced (by which primarily active self-monitoring of blood glucose) activities.

作者简介

E. Doskina

Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation; Moscow S.P.Botkin City Clinical Hospital, Moscow Healthcare Department

Email: Elena-doskina@rambler.ru
канд. мед. наук, доц. каф. эндокринологии и диабетологии ГБОУ ДПО РМАПО

B. Tankhilevich

Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation; Moscow S.P.Botkin City Clinical Hospital, Moscow Healthcare Department

канд. мед. наук, зав. отд-нием реанимации для кардиологических больных ГУЗ ГКБ им. С.П.Боткина

参考

  1. Antman E.M., Tanasijevic M.J., Thompson B et al. Cardiac - specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. NEJM 1996; 335 (18): 1342–9.
  2. Balkau B, Simon D. Survival in people with type 2 diabetes as a function of HbA(1c). Lancet 2010; 375 (9713): 438–40.
  3. Balkau B.New diagnostic criteria for diabetes and mortality in older adults. DECODE Study Group. European Diabetes Epidemiology Group. Lancet 1999; 353 (9146): 68–9.
  4. Becker A, Bos G, Vegt F et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow - up of the Hoorn Study. Eur Heart J 2003; 24 (15): 1406–13.
  5. Lee C.D., Folsom A.R., Pankow J.S. et al. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004; 109 (7): 855–60.
  6. Nathan D.M., Buse J.B., Davidson M.B. et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the study of Diabetes. Diabetes Care 2009; 32 (1): 193–203.
  7. Selvin E, Marinopoulos S, Berkenblit G et al. Meta - analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141 (6): 421–31.
  8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
  9. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non - insulin - dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28 (2): 103–17.
  10. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. NEJM 2008; 358: 2560–72.
  11. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. NEJM 2009; 360 (2): 129–39.
  12. Meinert C.L., Knatterud G.L., Prout T.E., Klimt C.R. A study of the effects of hypoglycemic agents on vascular complications in patients with adult - onset diabetes. II. Mortality results. Diabetes 1970; 19 (Suppl. 2): 789–830.
  13. ADA, Standards of Medical Care in Diabetes – 2011. Diabetes Care 2011; 34 (Suppl. 1).
  14. Amiel S A, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008; 25: 245–54.
  15. Доскина Е.В. Эндокринологические эпонимические синдромы и симптомы. М.: Энциклопедия, 2008.
  16. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. М., 2011; с. 9.
  17. Raine C.H., Schrock L.E., Edelman S.V., Mudaliar S.R.D. et al. Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters. J Diabetes Science Technology 2007; 1: 205–10.

版权所有 © Eco-Vector, 2013

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。

##common.cookie##